Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Reflow Medical, Inc.
Reflow Medical Reports One-Year Results from DEEPER CORONARY Study of Investigational Coronary Spur® Elute Sirolimus-Eluting Retrievable Stent System
Today 12:30 EST
From
Reflow Medical, Inc.
Via
Business Wire
CMS Approves New Technology Add-on Payment for Reflow Medical’s Spur® Peripheral Retrievable Stent System
September 01, 2026
From
Reflow Medical, Inc.
Via
Business Wire
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Spur® Peripheral Retrievable Scaffold System in a Select CLTI Cohort
July 02, 2026
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Reports Six-Month Results from DEEPER CORONARY Study of Spur® Elute Stent
May 20, 2026
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Announces U.S. Launch of Next-Generation Cora Flex® and Cora Force® Torqueable Microcatheters
April 23, 2026
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Announces 12-Month Results from DEEPER REVEAL Trial: Sustained Outcomes with the Spur® Stent System in CLTI
April 13, 2026
From
Reflow Medical, Inc.
Via
Business Wire
Spur® Elute DEEPER CORONARY Study Completes Enrollment
September 29, 2025
From
Reflow Medical, Inc.
Via
Business Wire
FDA Grants De Novo Clearance for Reflow Medical's Spur® Peripheral Retrievable Stent System
May 30, 2025
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Expands Global Reach with New European Subsidiary
March 07, 2025
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Enrolls First Patients in Pilot Study of Coronary Sirolimus-Eluting Retrievable Scaffold System (Spur Elute)
July 01, 2024
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Completes Enrollment in the DEEPER REVEAL Clinical Trial
May 09, 2024
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Receives CE Mark for Bare Temporary Spur Stent System for Treating de novo or Restenotic Below-the-Knee (BTK) Lesions
January 16, 2024
From
Reflow Medical, Inc.
Via
Business Wire
DEEPER OUS Trial Evaluating Reflow Medical’s Bare Temporary Spur Stent System Shows Positive Results at Six Months
June 13, 2023
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Introduces the coraCatheters™ Line and Expands into Complex Percutaneous Coronary Interventions (PCI)
May 19, 2023
From
Reflow Medical, Inc.
Via
Business Wire
First Patient Enrolled in Reflow Medical’s DEEPER REVEAL IDE Clinical Study
November 01, 2022
From
Reflow Medical, Inc.
Via
Business Wire
Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment
June 29, 2022
From
Reflow Medical, Inc.
Via
Business Wire
Enrollment Completed in Reflow Medical’s DEEPER OUS Clinical Trial
May 12, 2022
From
Reflow Medical, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.